Iron supplements may influence the development of colon cancer
Two common iron compounds increase the formation of a known biomarker for cancer...
List view / Grid view
Two common iron compounds increase the formation of a known biomarker for cancer...
In this In-Depth Focus; early biotherapeutic lead optimisation for more efficient drug discovery and development, and turning promising compounds into drug candidates.
Researchers aim to develop a new immunotherapy that could alter the immune reactions to food. The result: Extended relief from peanut allergies...
GB Sciences, Inc. is planning to file an Exploratory IND and perform a Phase 0 Clinical Trial to gather valuable First-In-Human data on its proprietary cannabis-based therapies...
In this issue; recent developments in turning promising compounds into drug candidates, reviewing the latest trends in pharmaceutical microbiology and their implications, and a roundtable debate featuring the views of five industry leaders.
Scientists have developed a new drug treating skin lesions in tuberous sclerosis complex (TSC), a rare intractable disease...
Sirolimus, which is used to prevent rejection after kidney transplants has been used to treat idiopathic pulmonary neuroendocrine cell hyperplasia...
New research points to the important role that benzodiazepines may have in depression...
A new cancer drug has proven safe and effective for paediatric patients with a rare tumour gene mutation...
Researchers develop a better delivery system for anti-inflammatory therapies...
Researchers have used kappa-carrageenan and nanosilicates to form injectable hydrogels to promote haemostasis and facilitate wound healing...
Combined treatment with two cancer immunotherapy drugs significantly prolonged survival in aggressive cancer malignant mesothelioma...
Testosterone therapy is not associated with a rise in oestrogen levels among transgender men, according to a new study led by Boston Medical Center...
By taking Zytiga with a low-fat meal could decrease the daily dose and prevent digestive issues...
Initiating an opioid analgesic reduced the use of antipsychotics and benzodiazepines in persons with Alzheimer's disease...